MSTN and type 1 diabetes mellitus: Our findings confirm elevated MSTN expression in STZ-T1D mice, with LIPUS exerting systemic metabolic benefits via local MSTN inhibition, suggesting MSTN suppression plays a pivotal role in LIPUS-mediated improvements.